Pregnancy-induced hypertension and insulin resistance, evidence for a connection

References

• Broughton Pipkin F, Runbin PC. Pre-eclampsia – the ‘disease of theories’. Br Med Bull 1994; 50(2): 381–96.
   Google Scholar
• Hargood JL, Brown MA. Pregnancy-induced hypertension: recurrence rate in second pregnancies. Med J Aust 1991; 154(6): 376–7.
   PubMedGoogle Scholar
• World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988; 158(1): 80–3.
   PubMed Web of Science ®Google Scholar
• Lindberg BS. Epidemiology of hypertension during pregnancy. Int J Technol Assess Health Care 1992; 8(Suppl 1): 57–62.
   Google Scholar
• Group NHBPEW. National High Blood Pressure Education Program Working Group Report on high blood pressure during pregnancy. Am J Obstet Gynecol 1990; 163: 1689–712.
   Google Scholar
• Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 1990; 163: 460–5.
   Google Scholar
• Svensson A. Hypertension in pregnancy. Clin Exp Hypertens 1993; 15(6): 1353–61.
   PubMed Web of Science ®Google Scholar
• Aberg H, Karlsson L, Melander S. Studies on toxaemia of pregnancy with special reference to blood pressure. Upsala J Med Sci 1978; 83: 29–34.
   Google Scholar
• Sibai BM, Gordon RH, Thom E, Caritis SN, Klebanoff M, McNellis D et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172(2 pt 1): 642–8.
   Google Scholar
• Cunningham FG, MacDonald PC, Grant NF. Hypertensive disorders in pregnancy. Williams Obstetrics. 18th ed. Norwalk: Appleton & Lange, 1989: 653–94.
   Google Scholar
• Davies AM, Czaczkes JW, Sadovsky E, Prywes R, Weiskopf P, Sterk VV Toxemia of pregnancy studies in Jerusalem, I.: Epidemiological studies of a total community. Isr J Med Sci 1970; 6: 253–66.
   PubMedGoogle Scholar
• Roberts JM. Pregnancy-related hypertension. In: Creasy R, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice. Second ed. Philadephia: WB. Saunders, 1989: 777–824.
   Google Scholar
• Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am J Hypertens 1995; 8(1): 1–4.14. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for pre-eclampsia. JAMA 1991; 266: 237–41.
   Google Scholar
• Jiang D. China: epidemiology of pregnancy-induced hypertension. World Health Stat Q – Rapport Trimestriel de Statistiques Sanitaires Mondiales 1995; 48(1): 8–10.
   Google Scholar
• Cooper DW, Brennecke SP, Wilton AN. Genetics of preeclampsia. Hypertens Preg 1993; 12(1): 1–23.
   Web of Science ®Google Scholar
• Cunningham F, Lindheimer M. Hypertension in pregnancy. New Eng J Med 1992; 326(14): 927–32.
   PubMed Web of Science ®Google Scholar
• Brown M, Buddle M. The importance of nonproteinuric hypertension in pregnancy. Hypertens Preg 1995; 14(1): 57–65.
   Web of Science ®Google Scholar
• Davey D, MacGilivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–8.
   PubMed Web of Science ®Google Scholar
• Kincaid-Smith P Hypertension in pregnancy. Blood Press 1994; 3(1–2): 18–23.
   Google Scholar
• Symonds E. Hypertension in pregnancy. Arch Dis Child Fetal Neonatal Ed 1995; 72(2): F139–44.
   Google Scholar
• Chesley LC. Hypertension in pregnancy: Definitions, familial factor, and remote prognosis. Kidney Int 1980; 18: 234–40.
   PubMed Web of Science ®Google Scholar
• Vinatier D, Monnier JC. Pre-eclampsia: physiology and immunological aspects. Eur J Obstet Gynecol Reprod Biol 1995; 61(2): 85–97.
   Google Scholar
• Handwerker SM, Altura BT, Altura BM. Ionized magnesium and calcium levels in umbilical cord serum of pregnant women with transient hypertension during labor. Am J Hypertens 1993; 6(6, Part 1): 542–5.
   Google Scholar
• Newman JC, Amarasingham. The pathogenesis of eclampsia: The ‘magnesium ischaemia’ hypothesis. Med Hypotheses 1992; 40: 250–66.
   Google Scholar
• Lalau JD, Jans I, el Esper N, Bouillon R, Fournier A. Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy. Am J Hypertens 1993; 6(6 pt 1): 522–7.
   Google Scholar
• Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995; 6(3): 232–7.
   PubMed Web of Science ®Google Scholar
• Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Friedman SA et al. New developments in pre-eclampsia. Fet Med Rev 1990; 2: 125–41.
   Google Scholar
• Dekker GA. Etiology and pathophysiology of preeclampsia. Zentralbl Gynakol 1994; 116(2): 57–60.
   Google Scholar
• Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 1991; 18(4): 661–82.
   PubMed Web of Science ®Google Scholar
• Schobel H, Fischer T, Heuszer K, Geiger H, Schieder R. Preeclampsia – a state of sympathetic overreactivity. N Engl J Med 1996; 335: 1480–5.
   PubMed Web of Science ®Google Scholar
• Fuh MM, Yin SS, Pei D et al. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens 1995; 8(7): 768–71.
   Google Scholar
• Solomon CG, Graves SW, Greene MF, Seely EW. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994; 23: 717–21.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Syndrome X: 6 years later. J Intern Med 1994; 236(Suppl. 736): 13–22.
   Google Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1495–607.
   Web of Science ®Google Scholar
• DeFronzo R, Farranni E. Insulin resistance. A multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 175–94.
   Google Scholar
• Steiner G. Hyperinsulinaemia and hypertriglyceridaemia. J Intern Med 1994; 236(Suppl. 736): 23–6.
   Google Scholar
• Haffner S. Progress in population analyses of the insulin resistance syndrome. Ann NY Acad Sci 1997; 827: 1–11.
   Google Scholar
• Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990; 13(6): 631–54.
   PubMed Web of Science ®Google Scholar
• Davidson DM. Preventive Cardiology. Baltimore: Williams and Wilkins, 1991.
   Google Scholar
• Reddy SSK. Reducing the incidence of coronary heart disease by managing hypertension: Implications of Syndrome X. Can J Pub Health 1994; 85\(Suppl. 2): S51–3.
   Google Scholar
• Wajchenberg BL, Malerbi DA, Rocha MS, Lerario AC, Santomauro AT. Syndrome X: A syndrome of insulin resistance. Epidemiological and clinical evidence. Diabetes Metab Rev 1994; 10(1): 19–29.
   Google Scholar
• McCarty MF. Hemostatic concomitants of Syndrome X. Med Hypotheses 1995; 44: 179–93.
   Google Scholar
• Vague P, Raccah D, Scelles V. Hypofibrinolysis and the insulin resistance syndrome. Int J Obes 1995; 19\(Suppl. 1): S12–S15.
   Google Scholar
• Bressler P, Bailey S, Matsuda M, DeFronzo R. Insulin resistance and coronary artery disease. Diabetologia 1996; 39(11): 1345–50.
   PubMed Web of Science ®Google Scholar
• Valdez R, Athens MA, Thompson GH, Bradshow BS, Stern MP. Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia 1994; 37: 624–31.
   Google Scholar
• Schmidt M, Watson R, Duncan R, Metcaff P, Brancattik FL, Sharrett R et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996; 45(6): 699–706.
   Google Scholar
• Despres J-P, Lemieux S, Lamarche B, Prud D, Moorjani S, Burn L-D et al. The insulin resistance-dyslipidemic syndrome: Contribution of visceral obesity and therapeutic implications. Int J Obes 1995; 19(Suppl 1): S76–S86.
   Google Scholar
• Zavaroni I, Bonini L, Fantussi M, Dall’Alglio E, Passeri M, Reaven GM. Hyperinsulinemia, obesity, and syndrome X. J Intern Med 1994; 235: 51–6.
   Google Scholar
• Sowers JR, Sowers PS, Peuler JD. Role of insulin resistance and hyperinsulinemia in the development of hypertension and atherosclerosis. J Lab Clin Med 1994; 123: 647–52.
   Google Scholar
• Popkin BM. The nutrition transition in low-income countries. Nutr Rev 1994; 52: 285–98.
   PubMed Web of Science ®Google Scholar
• Posner BM, Franz M, Quatromoni P Nutrition and the global risk for chronic diseases: the INTERHEALTH Nutrition Initiative. Nutr Rev 1994; 52(6): 210–17.
   Google Scholar
• Dorner GaP, A. Perinatal hyperinsulinism as possible predisposing factor for Diabetes Mellitus, obesity, and enhanced cardiovascular risk in later life. Horm Metab Res 1994; 26: 213–21.
   Google Scholar
• Dietz WH. Critical periods in childhood for the development of obesity. Am J Clin Nutr 1994; 59: 955–9.
   PubMed Web of Science ®Google Scholar
• Stewart D, Monge J. Hyperlipidaemia and endothelial dysfunction. Curr Opin Lipidol 1993; 4: 319–24.
   Google Scholar
• Sattar N, Gaw A, Packard C, Greer I. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Obstet Gynaecol 1996; 103(7): 614–20.
   PubMedGoogle Scholar
• Betteridge DJ. Diabetes, lipoprotein metabolism, and atherosclerosis. Br Med Bull 1989; 45(1): 285–311.
   PubMedGoogle Scholar
• Luscher TF, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertens 1993; 6(2): 283S-93S.
   Google Scholar
• Haig D. Genetic conflicts in pregnancy. Q Rev Biol 1993; 68(4): 495–532.
   PubMedGoogle Scholar
• Reece EA, Homko C, Wiznitzer A. Metabolic changes in diabetic and nondiabetic subjects during pregnancy. Obstet Gynecol Survey 1994; 49(1): 64–71.
   Google Scholar
• Friedman SA, Lubarsky SL, Ahokas RA, Nova A, Sibai BM. Preeclampsia and related disorders. Clinical aspects and relevance of endothelin and nitric oxide. Clinics in Perinatol 1995; 22(2): 343–55.
   Google Scholar
• Carpenter MW Metabolic changes in gestational diabetes. Clin Perinatol 1993; 20(3): 583–91.
   Google Scholar
• Ryan E, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1991; 67(2): 341–7.
   Google Scholar
• Laatikainen T, Virtanen T, Kaaja R, Salminen-Lappalainen K. Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1991; 39(1): 19–24.
   Google Scholar
• Catalano PM, Tyzbir ED, Roman N, Amini SB, Sims E. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 1667–72.
   Google Scholar
• Weiner CP Preeclampsia-eclampsia syndrome and coagulation. Clin Perinatol 1991; 18(4): 713–26.
   Google Scholar
• Halligan A, Bonner J, Sheppard B, Darling M, Walsh J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994; 101(6): 488–92.
   Google Scholar
• de Boer K, ten Cate JW, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95–9.
   PubMed Web of Science ®Google Scholar
• Stirling Y, Woolf L, North W, Seghatchian M, Meade T Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 124–6.
   Google Scholar
• Manson JE, Rimm EB, Colditz GA, Stampfer MJ, Willet WC, Arky RA et al. Parity and incidence of non-insulindependent diabetes mellitus. Am J Med 1992; 93(1): 1318.
   Google Scholar
• Charles MA, Pettitt DJ, McCance DR, Hanson RL, Bennett PH, Knowler WC. Gravidity, obesity, and non-insulin-dependent diabetes among Pima Indian women. Am J Med 1994; 97(3): 250–5.
   Google Scholar
• Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155: 1011–16.
   PubMed Web of Science ®Google Scholar
• Coustan DR. Gestational diabetes. Diabetes in America. 2nd ed. Washington, D.C.: National Institutes of Diabetes and Digestive and Kidney Diseases, NIH, 1995: vol NIH Publication No. 95–1468.
   Google Scholar
• Dornhorst A. Implications of gestational diabetes for the health of the mother. Br J Obstet Gynaecol 1994; 101: 286–90.
   PubMedGoogle Scholar
• Rewers M, Hamman RF. Risk factors for non-insulin dependent diabetes. Diabetes in America. 2nd ed. Bethesda, MD: National Institute of Diabetes and Kidney and Digestive Diseases, 1995: 179–220.
   Google Scholar
• Lyall F, Greer IA. Pre-eclampsia: a multifaceted vascular disorder of pregnancy. J Hypertens 1994; 12: 1339–45.
   PubMed Web of Science ®Google Scholar
• Langford H, Watson R. Pre-pregnant blood pressure, hypertension during pregnancy, and later blood pressure of mothers and offspring. Hypertension 1980; Suppl 1: 1130–3.
   Google Scholar
• Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynecol 1991; 165(1): 160–72.
   PubMed Web of Science ®Google Scholar
• Benedetto C, Marozio L, Giarola M, Chiarolini L, Maula V, Massobrio M. Twenty-four hour blood pressure monitoring in early pregnancy: is it predictive of pregnancy-induced hypertension and preeclampsia? Acta Obstet Gynecol Scand 1998; 77: 14–21.
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Buzzigoli G, Bonnadonna R et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7.
   PubMed Web of Science ®Google Scholar
• Jeng J-R, Sheu W-H, Jeng C-Y, Huang S-H, Shieh S-M. Impaired fibrinolysis and insulin resistance in patients with hypertension. Am J Hypertens 1996; 9: 484–90.
   PubMed Web of Science ®Google Scholar
• Bhanot S, McNeill J. Insulin and hypertension: a causal relationship? Cardiovasc Res 1996; 31: 212–21.
   PubMed Web of Science ®Google Scholar
• Wellborn TA, Breckenridge A, Rubinstein AH et al. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; 1: 1336–7.
   Google Scholar
• Berglund G, Larsson B, Andersson O, Larsson O, Svardsudd K, Bjortorp P et al. Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med Scand 1976; 200: 163–9.
   PubMedGoogle Scholar
• Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M et al. Hyperinsulinemia: a link between hypertension, obesity, and glucose tolerance. J Clin Invest 1985; 75: 80917.
   Web of Science ®Google Scholar
• Lucas C, Estigarribia J, Darga L, Reaven G. Insulin and blood pressure in obesity. Hypertension 1985; 7: 702–6.
   PubMed Web of Science ®Google Scholar
• Singer P, Godicke W, Voight S, Hajdu I, Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 1985; 7: 182–6.
   PubMed Web of Science ®Google Scholar
• Ferrari P, Weidmann P. Insulin, insulin sensitivity and hypertension. J Hypertens 1990; 8: 491–500.
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Haffner S, Stern M. Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol 1990; 15(Suppl 5): S18–S25.
   Google Scholar
• Reaven GM. Relationship between insulin resistance and hypertension. Diabetes Care 1991; 14: 33–8.
   PubMed Web of Science ®Google Scholar
• Faulkner B, Hulman S, Tannebaum J et al. Insulin resistance and blood pressure in young black men. Hypertension 1990; 16: 36–43.
   Google Scholar
• Faulkner B, Hulman S, Kushner H. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 1993; 22: 18–25.
   Google Scholar
• Iimura O. Insulin resistance and hypertension in Japanese. Hypertens Res 1996; 19(Suppl 1): S1–8.
   Google Scholar
• Van Minh H, Thanh L, Thi B, do Trinh T, Tho T, Valensi P. Insulinaemia and slight overweight: the case of Vietnamese hypertensives. Int J Obes Relat Metab Disord 1997; 21(10): 897–902.
   Google Scholar
• Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin P. Essential hypertension is associated with decreased insulin clearance and insulin resistance. Hypertension 1997; 29(1, Pt 1): 111–14.
   Google Scholar
• Donahue R, Bean J, Donahue R, Goldberg R, Prineas R. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Vasc Biol 1997; 17(11): 2413–17.
   Google Scholar
• Mgonda Y, Ramaiya K, Swai A, McLarty D, Alberti K. Insulin resistance and hypertension in non-obese Africans in Tanzania. Hypertension 1998; 31(1): 114–18.
   Google Scholar
• Klimes I, SeboKova E. Hypertension and the insulin resistance syndrome of rats. Are they related? Ann NY Acad Sci 1997; 87: 13–34.
   Google Scholar
• Charles MA, Pettitt DJ, Hanson RL, Bennett PH, Saad MF, Liu QZ et al. Familial and metabolic factors related to blood pressure in Pima Indian children. Am J Epidemiol 1994; 140(2): 123–31.
   Google Scholar
• Breschi M, Seghieri G, Bartolomei G, Gironi A, Baldi S, Ferrannini E. Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia 1993; 36: 1315–21.
   PubMed Web of Science ®Google Scholar
• Ashe S, Wingard D, Barrett-Conner E. Are insulin and hypertension independently related? Ann Epidemiol 1991; 1: 231–44.
   Google Scholar
• Manolio T, Savage P, Burke G et al. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA study. Atherosclerosis 1990; 10: 430–6.
   Google Scholar
• Collins V, Dowse G, Finch C, Zimmet P. An inconsistent relationship between insulin and blood pressure in three Pacific Island populations. J Clin Epidemiol 1990; 43: 1369–78.
   PubMed Web of Science ®Google Scholar
• Mbanya J, Thomas T, Wilkonson R, Alberti K, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet 1988; 1: 733–4.
   Google Scholar
• Saad M, Knowler W, Pettitt D, Nelson R, Mott D, Bennett P. Insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990; 39: 1430–5.
   PubMed Web of Science ®Google Scholar
• Dowse GK, Collins VR, Alberti KG, Zimmet PZ, Tuomilehto J, Chitson P et al. Insulin and blood pressure levels are not independently related in Mauritians of Asian, Indian, Creole or Chinese origin. The Mauritius non-communicable disease study group. J Hypertens 1993; 11: 297–307.
   Google Scholar
• Saad M, Lillioja S, Myomba BL, Castillo C et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991; 324(11): 733–9.
   PubMed Web of Science ®Google Scholar
• Denker P, Pollock V. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch Intern Med 1992; 152(8): 1649–51.
   Google Scholar
• Reaven G. Are insulin resistance and/or compensatory hyperinsulinemia involved in the etiology and clinical course of patients with hypertension? Int J Obesity 1995; 19(Suppl 1): S2–S5.
   Google Scholar
• Lind L, Pollare T, Berne C, Lithell H. Long term metabolic effects of antihypertensive drugs. Am Heart J 1994; 128: 1177–83.
   PubMed Web of Science ®Google Scholar
• Beatty OL, Harper OL, Sheridan B, Atkinson AB. Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307: 92–6.
   PubMed Web of Science ®Google Scholar
• Facchini F, Chen Y, Ckinkingbeard C, Jeppesen J, Reaven G. Insulin resistance, hyperinsulinemia and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 1992; 5: 694–9.
   PubMed Web of Science ®Google Scholar
• Ferrari P, Weidmann P, Shaw S et al. Altered insulin sensitivity, hyperinsulinemia, an adyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91: 589–96.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Valdez RA, Hazuda HP et al. Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes 1992; 41: 715–22.
   PubMed Web of Science ®Google Scholar
• Niskanen L, Uusitupa M, Pyörälä K. The relationship of hyperinsulinemia to the development of hypertension in type 2 diabetic patients and in non-diabetic subjects. J Hum Hypertens 1991; 5: 155–9.
   PubMed Web of Science ®Google Scholar
• Lissner L, Bengtsson L, Lapidus L, Kristjansson K, Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 1992; 20: 797–801.
   Google Scholar
• Shetterly SM, Rewers M, Hamman RF, Marshall JA. Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites: the San Luis Valley Diabetes Study. J Hypertens 1994; 12: 1095–102.
   PubMed Web of Science ®Google Scholar
• Salomaa VV, Strandberg TE, Vanhanen H, Naukkarinen V Sarna S, Miettinen TA. Glucose tolerance and blood pressure: long term follow up in middle aged men. BMJ 1991; 302: 493–6.
   Google Scholar
• Pershadsingh H, Szollosi J, Benson S, Hyun W, Feuerstein B, Kurtz T. Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension 1993; 21(6, Pt 2): 1020–3.
   Google Scholar
• Kemnitz J, Elson D, Roecker E, Baum S, Bergman R, Meglasson M. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant rhesus monkeys. Diabetes 1994; 43: 204–11.
   PubMed Web of Science ®Google Scholar
• Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 1995; 8: 316–20.
   Google Scholar
• Henry R. Effects of troglitazone on insulin sensitivity. Diab Med 1996; 13(9 Suppl 6): S148–50.
   Google Scholar
• Sechi L, Bartoli E. Mechanisms of insulin resistance leading to hypertension: what we can learn from experimental models. J Investig Med 1997; 45(5): 238–51.
   Google Scholar
• Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone; implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96(11): 41–4–13.
   Google Scholar
• Baron A. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Bailliere’s Clin Endocrinol Metab 1993; 7: 961–87.
   Google Scholar
• Axelrod L. Insulin, prostaglandins, and the pathogenesis of hypertension. Diabetes 1991; 40: 1223–7.
   Google Scholar
• Rowe J, Young J, Minaker K, Stevens A, Palotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 98(30): 219–25.
   Google Scholar
• Zemel M, Zemel P, Berry S et al. Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Eng J Med 1990; 323: 434–8.
   PubMed Web of Science ®Google Scholar
• Zemel M, Johnson B, Zemel P. Ca2+ transport and insulin resistance in pregnancy-induced hypertension (abstr). Hypertension 1990; 16: 318.
   Google Scholar
• Oian P, Kjeldsen SE, Eide I, Maltau JM. Increased arterial catecholamines in pre-eclampsia. Acta Obstet Gynecol Scand 1986; 65(6): 613–17.
   Web of Science ®Google Scholar
• Khatun S, Kanayama N, Hossain B, el Maradny E, Kobayashi T, Jahan S et al. Increased concentrations of plasma epinephrine and norepinephrine in patients with eclampsia [corrected and republished article originally printed in Eur J Obstet Gynecol Reprod Biol 1996 Nov; 69(2): 61–7]. Eur J Obstet Gynecol Reprod Biol 1997; 74(1): 103–9.
   Google Scholar
• Meekins J, Pijnenborg R, Hanssens M, McFadyen I, Van Assche A. A study of placental bed spiral arteries and trophoblast in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994; 101(8): 669–74.
   Google Scholar
• Pijinborg R, Anthony J, Davey D, Rees A, Tiltman A, Vercruysse L et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648–55.
   Google Scholar
• Barton J, Hiett A, O’Connor W, Nissen S, Greene J. Endomyocardial ultrastructural finding in preeclampsia. Am J Obstet Gynecol 1991; 165: 389–91.
   PubMed Web of Science ®Google Scholar
• Hubel C, McLaughlin M, Evans R, Hauth B, Sims C, Roberts J. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174(3): 975–82.
   PubMed Web of Science ®Google Scholar
• Salameh WA, Mastrogiannis DS. Maternal hyperlipidemia in pregnancy. Clin Obstet Gynecol 1994; 37(1): 66–77.
   Google Scholar
• Hostmark AT. Serum fatty acid/albumin molar ratio and the risk of disease. Med Hypotheses 1995; 44(6): 539–41.
   Google Scholar
• Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity of sera from pre-eclamptic women due to the presence of a lysophospholipase. Scand J Clin Lab Investig 1993; 53(7): 733–9.
   Google Scholar
• Murai J, Muzykanskiy E, Taylor R. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metab Clin Exp 1997; 46(8): 963–7.
   Google Scholar
• Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. Diabetes in America. 2nd ed. Bethesda, MD: National Institute of Diabetes and Kidney and Digestive Diseases, 1995: 117–64.
   Google Scholar
• Bjorntorp P. Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? Curr Opin Lipidol 1994; 5(3): 166–74.
   Google Scholar
• van den Elzen HJ, Wladimiroff JW, Cohen-Overbeek TE, de Bruijn AJ, Grobbee DE. Serum lipids in early pregnancy and risk of pre-eclampsia. Br J Obstet Gynaecol 1996; 103(2): 117–22.
   Google Scholar
• Lorentzen B, Endresen M, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks gestation in women who later develop preeclampsia. Hypertens Preg 1994; 13: 103–9.
   Web of Science ®Google Scholar
• Lorentzen B, Drevon C, Endresen M, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol 1995; 102: 530–7.
   PubMedGoogle Scholar
• Lobo RA. Lipids, clotting factors, and diabetes: endogenous risk factors for cardiovascular disease. Am J Obstet Gynecol 1988; 158(6 Pt 2): 1584–91.
   Google Scholar
• Lorentzen B, Endresen MJ, Hovig T, Haun E, Henrikson T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991; 63: 36372.
   Google Scholar
• Endresen M, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167: 440–7.
   Google Scholar
• Reaven GM, Chen Y-D. The role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988; 4: 639–52.
   Google Scholar
• Sowers J, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. Hypertension 1995; 26(6, Pt 1): 869–79.
   Google Scholar
• Lim K-H, Friedman SA. Hypertension in pregnancy. Curr Opin Obstet Gynecol 1993; 5: 40–9.
   Google Scholar
• Ballegeer V, Spitz B, De Baene L, Van Assche A, Hidajat M, Criel A. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 1992; 166(2): 629–33.
   Google Scholar
• Pritchard JA, Cunningham FG, Mason RA. Does coagulation have a causative role in eclampsia? Perspect Nephrol Hypertens 1976; 5: 95–102.
   Google Scholar
• Fitzgerald M, Floro C, Siegel J, Hernandez E. Laboratory findings in hypertensive disorders of pregnancy. J Nat Med Assoc 1996; 88(12): 794–8.
   Google Scholar
• Shaarawy M, Didy H. Thrombomodulin, plaminogen activator inhibitor type I (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet 1996; 55(2): 135–9.
   Google Scholar
• Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournie A et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or preeclampsia. Br J Obstet Gynaecol 1993; 100(5): 416–20.
   PubMedGoogle Scholar
• Hsu CD, Iriye B, Johnson TR, Witter FR, Hong SF, Chan DW Elevated circulating thrombomodulin in severe preeclampsia [published erratum appears in Am J Obstet Gynecol 1994 Oct; 171(4): 1165]. Am J Obstet Gynecol 1993; 169(1): 148–9.
   Google Scholar
• Roberts J, Redman C. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447–50.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995; 80(6): 1888–93.
   PubMed Web of Science ®Google Scholar
• Friedman S, Schiff E, Emeis J, Dekker G, Sibai B. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 1995; 172(1 Pt 1)): 202–3.
   Google Scholar
• Kloczko J, Wojtukiewicz MZ, Bielawiec M, Galar M, Tarasow E. von Willebrand factor antigen and fibronectin in essential hypertension. Thromb Res 1995; 79(3): 331–6.
   Google Scholar
• Garcia Frade LJ, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffney PJ. Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb Res 1987; 47(5): 533–40.
   Google Scholar
• Inoguchi T, Umeda F, Watanabe J, Wasada T, Ibayashi H. Plasma fibronectin and platelet aggregation in diabetes mellitus. Diabetes Res Clin Pract 1986; 2(2): 69–73.
   Google Scholar
• Brubaker DB, Ross MG, Marinoff D. The function of elevated plasma fibronectin in preeclampsia. Am J Obstet Gynecol 1992; 166: 526–31.
   PubMed Web of Science ®Google Scholar
• Ballegeer V, Spitz B, Kieckens L, Moreau H, Van Assche A, Collen D. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 1989; 161: 432–6.
   PubMed Web of Science ®Google Scholar
• Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991; 165: 895–901.
   PubMed Web of Science ®Google Scholar
• Pekonen F, Rasi V, Ammala M, Viinikka L, Ylikorkala O. Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 1986; 43(5): 553–60.
   Google Scholar
• Redman CW, Denson KW, Beilin LJ, Bolton FG, Stirrat GM. Factor-VIII consumption in pre-eclampsia. Lancet 1977; 2(8051): 1249–52.
   Google Scholar
• Perry KG, Jr, Martin JN, Jr. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol 1992; 35(2): 338–50.
   Google Scholar
• Green D, Ruth KJ, Folsom AR, Lui K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arterioscler Thromb 1994; 14: 686–93.
   Google Scholar
• Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII, and fibrinogen in an industrial population, II: baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985; 54: 721–3.
   Google Scholar
• Folson AR, Wu KK et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191–205.
   Google Scholar
• Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 1996; 94: 2171–6.
   Google Scholar
• Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 1995; 15(8): 1114–20.
   PubMed Web of Science ®Google Scholar
• Donders SH, Lustermans FA, van Wersch JW. Glycometabolic control, lipids, and coagulation parameters in patients with non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 1993; 23(3): 155–9.
   Google Scholar
• Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM Study in healthy men. Arterioscler Thromb 1994; 14: 54–9.
   Google Scholar
• Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North W et al. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2(8506): 533–7.
   PubMed Web of Science ®Google Scholar
• Jansson J-H, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent infarction and death. Br Heart J 1991; 66: 351–5.
   Google Scholar
• Thompson SG, Kienast J, Pyke S, Haverkate F, van de Loo J. Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635–41.
   Google Scholar
• Kario K, Miyata T, Sakata T, Matsuo T, Kato H. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. Arterioscler Thromb 1994; 14(2): 265–74.
   Google Scholar
• Di Iorio R, Marinoni E, Anceschi MM, Emiliani S, Letizia C, Cosmi EV Amniotic fluid endothelin-1 levels are increased in pregnancy-induced hypertension and intrauterine growth retardation. Am J Reprod Immunol 1996; 36(5): 260–3.
   Google Scholar
• Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993; 169(1): 160–5.
   PubMed Web of Science ®Google Scholar
• Ferri C, Pittoni V Piccoli A et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995; 80(3): 829–35.
   Google Scholar
• Hasegawa M, Sagawa N, Nanno H et al. Endothelin-1-like immunoreactivity and endothelin receptors in the human placenta from normotensive and hypertensive pregnancies. J Perinat Med 1996; 24(5): 451–60.
   Google Scholar
• Liang X, Lin Y, Cheng Y. [Changes in plasma endothelin-1 and lipid peroxidate levels and amount of superoxidate dismutase in red blood cell in patients with pregnancy-induced hypertension]. Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology] 1996; 31(4): 220–2.
   Google Scholar
• Klockenbusch W, Somville T, Hafner D, Strobach H, Schror K. Excretion of prostacyclin and thromboxane metabolites before, during, and after pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 1994; 57(1): 47–50.
   Google Scholar
• Zahradnik HP, Schafer W, Wetzka B, Breckwoldt M. Hypertensive disorders in pregnancy. The role of eicosanoids. Eicosanoids 1991; 4(3): 123–36.
   Google Scholar
• de Jong CL, Dekker GA, Sibai BM. The renin-angiotensin-aldosterone system in preeclampsia. A review. Clin Perinatol 1991; 18(4): 683–711.
   Google Scholar
• Schramek H, Coroneos E, Dunn MJ. Interactions of the vasoconstrictor peptides, angiotensin II and endothelin-1, with vasodilatory prostaglandins. Semin Nephrol 1995; 15(3): 195–204.
   Google Scholar
• Ishii H, Umeda F, Nawata H. Platelet function in diabetes mellitus. Diabetes Metab Rev 1992; 8(1): 53–66.
   Google Scholar
• Pitei DL, Watkins PJ, Edmonds ME. NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med 1997; 14(4): 284–90.
   Google Scholar
• Higashi Y, Oshima T, Sasaki N, Ishioka N, Nakano Y, Ozono R et al. Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension 1997; 29(1 Pt 2): 280–5.
   Google Scholar
• Schiffrin EL. The endothelium of resistance arteries: physiology and role in hypertension. Prostaglandins Leukot Essent Fatty Acids 1996; 54(1): 17–25.
   Google Scholar
• Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267(2 Pt 1): E187–202.
   Google Scholar
• Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O et al. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 1995; 18(2): 226–33.
   Google Scholar
• Ferri C, Laurenti O, Bellini C, Faldetta MR, Properizi G, Santucci A et al. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Am J Hypertens 1995; 8: 40–7.
   PubMed Web of Science ®Google Scholar
• Ahlawat S, Pati HP, Bhatla N, Fatima L, Mittal S. Plasma platelet aggregating factor and platelet aggregation studies in pre-eclampsia. Acta Obstet Gynecol Scand 1996; 75(5): 428–31.
   Google Scholar
• Elder MG. Is pre-eclampsia preventable? Ann Med 1991; 23(6): 671–3.
   PubMed Web of Science ®Google Scholar
• Giles C, Inglis TC. Thrombocytopenia and macrothrombocytosis in gestational hypertension. Br J Obstet Gynaecol 1981; 88(11): 1115–19.
   PubMedGoogle Scholar
• de Vries JI, Vellenga E, Aarnoudse JG. Plasma beta-thromboglobulin in normal pregnancy and pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 1983; 14(4): 209–16.
   Google Scholar
• Inglis TC, Stuart J, George AJ, Davies AJ. Haemostatic and rheological changes in normal pregnancy and preeclampsia. Br J Haematol 1982; 50(3): 461–5.
   Google Scholar
• Janes S, Goodall A. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci 1994; 86(6): 7319.
   Google Scholar
• Tozzi-Ciancarelli MG, Di Massimo C, D’Alfonso A, Caserta D, Moscarini M. Pregnancy-induced hypertension: evidence for altered functional features of platelets. Hypertens Pregn 1994; 13: 33–41.
   Google Scholar
• Walsh SW, Wang Y, Jesse R. Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertens Pregn 1996; 15(1): 101–11.
   Google Scholar
• Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992; 166(1 pt 1): 224–30.
   Google Scholar
• Lin PJ, Chang CH, Pearson PJ, Tzen KY, Chan JJ, Chang JP et al. Thromboxane A-2: An endothelium-derived vasoconstrictor in human internal mammary arteries. Ann Thorac Surg 1993; 56(1): 97–100.
   Google Scholar
• Carter AJ, Heptinstall S. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate. Thromb Haemost 1985; 54(3): 612–16.
   Google Scholar
• Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem 1986; 55: 69–102.
   PubMed Web of Science ®Google Scholar
• Katayama S, Inaba M, Maruno Y, Omoto A, Kawazu S, Ishii J et al. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2. Prostaglandins Leukot Essent Fatty Acids 1990; 39(1): 47–51.
   Google Scholar
• Caron C, Goudemand J, Marey A, Beague D, Ducroux G, Drouvin F. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost 1991; 66(4): 410–14.
   Google Scholar
• Lox CD, Word RA, Corrigan JJ. Effects of preeclampsia on maternal and cord blood clotting activity. Am J Perinatol 1985; 2(4): 279–82.
   Google Scholar
• Bremme K, Blomback M. Hemostatic abnormalities may predict chronic hypertension after preeclampsia. Gynecol Obstet Invest 1996; 41(1): 20–6.
   Google Scholar
• Mutoh S, Kobayashi M, Hirata J, Itoh N, Maki M, Komatsu Y et al. Studies of blood coagulation-fibrinolysis regarding kallifrein-kinin system in severe preeclampsia. Agents Actions Suppl 1992; 38(Pt 2): 342–9.
   Google Scholar
• Terao T, Maki M, Ikenoue T, Gotoh K, Murata M, Iwasaki H et al. The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. Gynecol Obstet Invest 1991; 31(2): 74–85.
   Google Scholar
• McKillop C, Forbes CD, Howie PW, Prentice CM. Soluble fibrinogen/fibrin complexes in pre-eclampsia. Lancet 1976; 1(7950): 56–8.
   Google Scholar
• Ho CH, Yang ZL. The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost 1992; 67(2): 214–18.
   PubMed Web of Science ®Google Scholar
• Parasnis H, Raje B, Hinduja IN. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med 1992; 38(4): 183–5.
   Google Scholar
• Estelles A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989; 74(4): 1332–8.
   Google Scholar
• Saleh AA, Bottoms SF, Gerbasi FR, Mammen EF Hemostasis and diagnosis of preeclampsia. Thromb Res 1994; 75(2): 163–71.
   Google Scholar
• Savelieva GM, Efimov VS, Grishin VL, Shalina RI, Kashezheva AZ. Blood coagulation changes in pregnant women at risk of developing preeclampsia. Int J Gynaecol Obstet 1995; 48(1): 3–8.
   Google Scholar
• Sen C, Madazh R, Kavuzlu C, Ocak V Tolun N. The value of antithrombin-III and fibronectin in hypertensive disorders of pregnancy. J Perinat Med 1994; 22(1): 29–38.
   Google Scholar
• Graninger W, Tatra G, Pirich K, Nasr F Low antithrombin III and high plasma fibronectin in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1985; 19: 223–9.
   PubMedGoogle Scholar
• Bontis J, Vavilis D, Agorastos T, Zournatzi V, Konstantinidis T, Tagou K. Maternal plasma level of thrombomodulin is increased in mild preeclampsia. Eur J Obstet Gynecol Reprod Biol 1995; 60(2): 139–41.
   Google Scholar
• Minakami H, Takahashi T, Izumi A, Tamada T. Increased levels of plasma thrombomodulin in preeclampsia. Gynecol Obstet Invest 1993; 36(4): 208–10.
   Google Scholar
• Kanfer A, Bruch JF, Nguyen G, He CJ, Delarue F, Hahault A et al. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest 1996; 74(1): 253–8.
   Google Scholar
• Oida K, Takai H, Maeda H, Takahashi S, Tamai T, Nakai T et al. Plasma thrombomodulin concentration in diabetes mellitus. Diabetes Res Clin Pract 1990; 10(2): 1936.
   Google Scholar
• Davi G, Gennaro F, Spatola A, Catalano I, Averna M, Montalto G et al. Thrombin-antithrombin III complexes in type II diabetes mellitus. J Diabetes Complications 1992; 6(1): 7–11.
   Google Scholar
• Morishita E, Asakura H, Jokaji H et al. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis 1996; 120(1–2): 7–14.
   Google Scholar
• Shimizu H, Ohtani K, Tanaka Y et al. Increased plasma thrombin-antithrombin III complex levels in non-insulin dependent diabetic patients with albuminuria are reduced by ethyl icosapentatenoate. Thromb Haemost 1995; 74(5): 1231–4.
   Google Scholar
• Donders SH, Lustermans FA, Van Wersch JW. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest 1993; 53(2): 179–86.
   Google Scholar
• Godsland IF, Crook D, Stevenson JC et al. Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. Br Heart J 1995; 74(1): 47–52.
   Google Scholar
• Eliasson M, Jansson JH, Nilsson P, Asplund K. Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden. J Hypertens 1997; 15(4): 349–56.
   Google Scholar
• Neri S, Bruno CM, Raciti C, D’Angelo G, D’Amico R, Cristaldi R. Alteration of oxide reductive and haemostatic factors in type 2 diabetics. J Int Med 1994; 236(5): 495500.
   Google Scholar
• Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchick J, Colwell JA. Hemostatic alterations with exercise conditioning in NIDDM. Diabetes Care 1990; 13(2): 87–92.
   Google Scholar
• Schmitz A, Ingerslev J. Haemostatic measures in type 2 diabetic patients with microalbuminuria. Diabet Med 1990; 7(6): 521–5.
   Google Scholar
• Scarabin PY, Vissac AM, Kirzin JM et al. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factorVII. Arterioscler Thromb Vasc Biol 1996; 16(9): 11706.
   Google Scholar
• Almer LO, Nilsson IM. On fibrinolysis in diabetes mellitus. Acta Med Scand 1975; 198(1–2): 101–6.
   Google Scholar
• Auwerx J, Bouillon R, Collen D, Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988; 8(1): 68–72.
   Google Scholar
• Avellone G, Di Garbo V, Cordova R et al. Blood coagulation and fibrinolysis in obese NIDDM patients. Diabetes Res 1994; 25(2): 85–92.
   Google Scholar
• Genest J Jr, Cohn JS. Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol 1995; 76(2): 8A-20A.
   Google Scholar
• Hamsten A, Eriksson P, Karpe F, Silveira A. Relationships of thrombosis and fibrinolysis to atherosclerosis. Curr Opin Lipidol 1994; 5(5): 382–9.
   Google Scholar
• Juhan-Vague I, Collen D. On the role of coagulation and fibrinolysis in atherosclerosis. Ann Epidemiol 1992; 2(4): 427–38.
   Google Scholar
• Grant PJ. The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects. Diabete Metab 1991; 17(1 Pt 2): 168–73.
   Google Scholar
• Bahru Y, Kesteven P, Alberti KG, Walker M. Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification. Diabet Med 1993; 10(9): 802–6.
   Google Scholar
• Yudkin JS. The Deidesheimer Meeting: Significance of classical and new risk factors in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1997; 11: 100–3.
   Google Scholar
• Kario K, Nago N, Kayaba K et al. Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study. Arterioscler Thromb Vasc Biol 1996; 16(2): 269–74.
   Google Scholar
• Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473–86.
   PubMed Web of Science ®Google Scholar
• Tooke JE. Microcirculation and diabetes. Br Med Bull 1989; 45(1): 206–23.
   Google Scholar
• Dunlop W, Davidson JM. The effect of normal pregnancy on the renal handling of uric acid. Br J Obstet Gynaecol 1977; 85: 938–40.
   Google Scholar
• Boyle JA, Campbell S, Duncan AM, Greig WR, Buchanan WW. Serum uric acid levels in normal pregnancy with observations of the renal excretion in pregnancy. Clin Sci Molec Med 1974; 47: 559–65.
   Google Scholar
• Clark B, Halvorson L, Sachs B, Epstein FH. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 1992; 166: 962–8.
   PubMed Web of Science ®Google Scholar
• Seitchik J. Metabolism of urate in pre-eclampsia. Am J Obstet Gynecol 1956; 72: 40–7.
   Google Scholar
• Seitchik J, Szurka A, Alper C. Further studies in the metabolism of N15-labelled uric acid in normal pregnancy and toxaemic pregnant women. Am J Obstet Gynecol 1958; 76: 1151–5.
   Google Scholar
• Fay RA. Uric acid in pregnancy and preeclampsia: an alternative hypothesis. Aust NZ J Obstet Gynaecol 1990; 30: 141–2.
   PubMed Web of Science ®Google Scholar
• Beaufils M, Uzan S, DojnSimoni R. Metabolism of uric acid in normal and pathologic pregnancy. Contrib Nephrol 1981; 25: 132–6.
   Google Scholar
• Carlsson C. Cardiovascular changes in preeclampsia. Am J Obstet Gynecol 1984; 150: 506–12.
   Google Scholar
• Yoshimura A, Ideura T, Iwasaki S, Kosikawa S. Significance of uric acid clearance in preeclampsia. Am J Obstet Gynecol 1990; 162(6): 1639–40.
   Google Scholar
• Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996; 174(1 Pt 1): 288–91.
   Google Scholar
• Voto LS, Illia R, Darbon-Grosso HA, Imaz FU, Margulies M. Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. J Perinatal Med 1988; 16: 123–6.
   Google Scholar
• Chen C-H, Lin H-C, Kuo H-S, Chang M-S, Chou P Epidemiology of hypertension in Kin-Hu, Kinmen. Am J Hypertens 1995; 8: 395–403.
   Google Scholar
• Selby J, Friedman G, Quesenberry C. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesteroland other serum chemistries. Am J Epidemiol 1990; 131: 1017–27.
   Google Scholar
• Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25–9.
   PubMed Web of Science ®Google Scholar
• Muscelli E, Natali A, Bianchi S et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996; 9: 746–52.
   PubMed Web of Science ®Google Scholar
• Zavaroni I, Mazza S, Fantuzzi M, Dall’ Aglio E, Bonora E, Delsignore R et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 1993; 234: 25–30.
   PubMed Web of Science ®Google Scholar
• Facchini F Chen Y-D, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary acid clearance, and plasma uric acid concentration. JAMA 1991; 266: 3008–11.
   Google Scholar
• Quinones-Galvan A, Natali A, Baldi S, Muscelli E, Baldari G, Pecori N et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268: E1–E5.
   Google Scholar
• Meekins J, Pijnenborg R, Hanssens M, Van Assche A, McFadyen I. Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe pre-eclamptic pregnancies. Placenta 1994; 15: 511–24.
   Google Scholar
• DeWolf F, Robertson W, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123: 164–74.
   PubMed Web of Science ®Google Scholar
• Robertson W, Khong T, Brosens I, Wolf F, Sheppard BI, Bonnar J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986; 159: 40112.
   Google Scholar
• Meekins J, Pijnenborg R, Hanssens M, McFadyen I, Van Assche F. Spiral artery morphology in pregnancies complicated by chronic hypertension: The relation to antihypertensive therapy and to superimposed preeclampsia. Hypertens Pregn 1995; 14(1): 67–80.
   Google Scholar
• Chwalisz K, Garfield R. Role of progesterone during pregnancy: models ofparturition and preeclampsia. Z Geburtshilfe Perinatol 1994; 198: 170–8.
   PubMedGoogle Scholar
• Scott J. Lipoprotein(a). BMJ 1991; 303: 663–4.
   Google Scholar
• Willeit J, Kiechl S, Santer P et al. Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Stroke 1995; 26(9): 1582–7.
   Google Scholar
• Pyoraia K, Uusitupa M, Laakso M, Siitonen O, Nisakanen L, Ronnemaa T. Macrovascular complications in relation to hyperinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes Metab 1987; 13: 345–9 Rev.
   Google Scholar
• Hillson R, Hockaday T, Mann J, Newton D. Hyperinsui is associated with development of electrocardiographic abnormalities in diabetics. Diabetes Res 1984; 1: 143–9.
   Google Scholar
• Ronnemaa T, Laakso M, Pyoraia K, Kallio V, Puukka P. High fasting plasma insulin as an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991; 11: 80–90.
   Google Scholar
• Standl E, Janka H. High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res 1985; 15 [Suppl]: 46–51.
   Google Scholar
• Welborn J, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Brusselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154–60.
   PubMedGoogle Scholar
• Fontbonne A, Charles M, Thibult N. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991; 34: 356–61.
   Google Scholar
• Yarnell J, Sweetnman P, Marks V, Teale J, Bolton C. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations. The Caerphilly prospective study. Br Heart J 1994; 171: 293–6.
   Google Scholar
• Despres J, Lamarche B, Mauriege P et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952–7.
   PubMed Web of Science ®Google Scholar
• McKeigue P, Ferrie J, Peirpoint T, Marmot M. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993; 87: 152–61.
   PubMed Web of Science ®Google Scholar
• Laakso M, Sarlund H, Salonen R et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991; 11: 1068–76.
   PubMed Web of Science ®Google Scholar
• Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study. Obstet Gynecol 1990; 76(6): 1061–9.
   PubMed Web of Science ®Google Scholar
• Parazzini F, Bortolus R, Chatenoud L et al. Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Epidemiology 1996; 7: 306–8.
   PubMed Web of Science ®Google Scholar
• Stone JL. Risk factors for severe pre-eclampsia. Obstet Gynecol 1994; 83(3): 357–61.
   PubMed Web of Science ®Google Scholar
• Hoag S, Marshall JA, Jones RH, Hamman RF. High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: The San Luis Valley Diabetes Study. Int J Obesity 1995; 19: 175–80.
   PubMed Web of Science ®Google Scholar
• Hamasaki T, Yasuhi I, Hirai M, Masuki H, Ishimaru T. Hyperinsulinemia increases the risk of gestational hypertension. Int J Gynaecol Obstet 1996; 55: 141–5.
   Google Scholar
• Gans R, Kraayenbrink A, van Geijn H, Dekker G. Insulin resistance characterizes pregnant women that will develop preeclampsia. Am J Hypertens 1996; 9: 132A (abs).
   Google Scholar
• Chesley LC. Hypertensive Disorders in Pregnancy. New York: Appleton-Century-Crofts, 1978.
   Google Scholar
• Suhonen L, Teramo K. Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand 1993; 72(4): 269–72.
   PubMed Web of Science ®Google Scholar
• Garner PR, D’Alton ME, Dudley DK, Huard P, Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990; 163(2): 505–8.
   PubMed Web of Science ®Google Scholar
• Schaffir JA, Lockwood CJ, Lapinski R, Yoon L, Alvarez M. Incidence of pregnancy-induced hypertension among gestational diabetics. Am J Perinatol 1994; 12(4): 252–4.
   Google Scholar
• Singh MM. Carbohydrate metabolism in pre-eclampsia. Br J Obstet Gynaecol 1976; 83: 124–31.
   PubMedGoogle Scholar
• Stander HJ, Harrison EPH. Carbohydrate metabolism in eclampsia. Am J Obstet Gynecol 1929; 18: 17–27.
   Google Scholar
• Burt RL. Peripheral utilization of glucose in pregnancy. II. Pre-eclampsia. Obstet Gynecol 1955; 6(1): 51–4.
   Google Scholar
• Burt RL. Peripheral utilization of glucose in pregnancy. IV: Reactivity to insulin in pre-eclampsia. Obstet Gynecol 1957; 9: 310–16.
   Google Scholar
• Govan AD, Mukherjee CL, Hewitt J, Harper WF. Studies of carbohydrate metabolism in pregnancy hypertension. J Obstet Gynaecol Br Emp 1951; 58: 788–804.
   Google Scholar
• Yamamoto K. Studies on plasma insulin in women. 2. Effect of glucose administration in the anovulatory cycle, toxemia of late pregnancy and glucosuria of pregnancy. Tokushima J Exp Med 1967; 14(3): 97–106.
   Google Scholar
• Madsen SN, Hindberg I, Molsted-Pedersen L. Insulin response to oral glucose in patients with preeclampsia. Dan Med Bull 1973; 20: 13–15.
   Google Scholar
• Long PA, Abell DA, Beischer NA. Importance of abnormal glucose tolerance (hypoglycaemia and hyperglycaemia) in the aetiology of pre-eclampsia. Lancet 1977; April 30: 923–5.
   Google Scholar
• Gu H, Rong L, Sai JY. Insulin resistance and pregnancy induced hypertension. Chin J Obstet Gynecol 1994; 29(12): 711–13.
   Google Scholar
• Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85(3): 353–6.
   PubMed Web of Science ®Google Scholar
• Martinez Abundis E, Gonzalez Ortiz M, Quinones Galvan A, Ferrannini E. Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study. Am J Hypertens 1996; 9: 610–14.
   PubMed Web of Science ®Google Scholar
• Lorentzen B, Birkeland K, Endresen M, Henriksen T. Glucose intolerance in women with preeclampsia. Acta Obstet Gynecol Scand 1998; 77: 22–7.
   PubMed Web of Science ®Google Scholar
• Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81(8): 2908–11.
   Google Scholar
• Sowers J, Standely P, Jacober S, Niyogi T, Simpson L. Postpartum abnormalities of carbohydrate and cellular calcium metabolism in pregnancy induced hypertension. Am J Hypertens 1993; 6: 302–7.
   Google Scholar
• Lindsay MK, Graves W, Klein L. The relationship of one abnormal glucose tolerance test value and pregnancy complications. Obstet Gynecol 1989; 73: 103–6.
   Google Scholar
• Sermer M, Naylor C, Gare D, Kenshole AB, Ritchie JW, Farine D et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995; 173(1): 146–56.
   PubMed Web of Science ®Google Scholar
• Kraayenbrink A, Gans R, van Geijn H, Dekker G. Insulin resistance, vasoactive mediators and preeclampsia. Am J Obstet Gynecol 1997; 176, pt 2(1): S26 (abs 57).
   Google Scholar
• Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137(9): 959–65.
   Google Scholar
• Paolisso G, Sgambato S, Guigliano D, Torella R, Varricchio M, Scheen AT et al. Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (noninsulin-dependent) diabetic patients. Diabetologia 1988; 31: 910–15.
   PubMedGoogle Scholar
• Nadler J, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21(6 Pt 2): 1024–9.
   Google Scholar
• Lindeberg S, Axelsson O, Jorner U, Malmberg L, Sandstrom B. A prospective controlled five-year follow up study of primiparas with gestational hypertension. Acta Obstet Gynecol Scand 1988; 67(7): 605–9.
   Google Scholar
• Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995; 102(11): 876–81.
   Google Scholar
• Leerink C, de Vries C, van der Klis F. Elevated levels of serum lipoprotein(a) and apoplipoprotein(a) phenotype are not related to pre-eclampsia. Acta Obstet Gynecol Scand 1997; 76: 625–8.
   PubMed Web of Science ®Google Scholar
• Jonsdottir L, Arngrimsson R, Geirsson R, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772–6.
   Google Scholar
• Chesley LC, Annitto JE, Cosgrove RA. The remote prognosis in toxemia of pregnancy. Clin Obstet Gynecol 1976; 9: 973.
   Google Scholar
• Eckel R, Yost T, Jensen D. Alterations in lipoprotein lipase in insulin resistance. Int J Obesity 1995; 19(Suppl 1): S16–21.
   Google Scholar
• Bjorntorp P Abdominal obesity and risk. Clin Exp Hypertens 1990; A12: 783–94.
   Google Scholar
• Girard J. Role of free fatty acids in the insulin resistance of non-insulin-dependent diabetes. Diabete Metab 1995; 21(2): 79–88.
   Google Scholar
• Brindley N. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obesity 1995; 19(Suppl 1): S69–75.
   PubMed Web of Science ®Google Scholar
• Arbogast B, Leeper S, Merrick R, Olive K, Taylor R. Plasma factors that determine endothelial cell lipid toxicity in vitro correctly identify women with preeclampsia in early and late pregnancy. Hypertens Pregn 1996; 15(3): 263–79.
   Google Scholar
• Austin MA, Selby J. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int J Obesity 1995; 19(Suppl 1): S22–6.
   Google Scholar
• Maseki M, Nishigaki I, Hagihara M, Tomoda K, Yugi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without preeclampsia. Clin Chim Acta 1981; 115: 155–61.
   Google Scholar
• Barkai G, Reichman B, Kokia E et al. Fluorescence polarization of serum lipids in pregnancies complicated by hypertensive disorder. J Perinat Med 1994; 22(2): 107–11.
   Google Scholar
• Tanaka A, Morikawa H, Tamasaki M, Takashima T, Gotoh K, Kanda M et al. Hyperlipidemia and endothelial cell dysfunction in preeclampsia. Hypertens Pregn 1995; 14(1): 126.
   Google Scholar
• Sciarrone S, Barden A, Croft K et al. Plasma lipids and plasma and urinary acetyl hydrolase activity in normal and hypertensive pregnancies. Hypertens Pregn 1996; 15(1): 75–86.
   Web of Science ®Google Scholar
• Donders SH, Lustermans FA, van Wersch JW. The effect of microalbuminuria on glycaemic control, serum lipids and haemostasis parameters in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 1993; 30(Pt 5): 439–44.
   Google Scholar
• Paternoster DM, Stella A, Simioni P, Girolami A, Plebani M. Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 70(1): 33–9.
   Google Scholar
• Deng L, Bremme K, Hansson LO, Blomback M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994; 84(6): 941–5.
   PubMedGoogle Scholar
• Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170(6): 1752–7.
   Google Scholar
• Stubbs TM, Lazarchick J, Horger EOD. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 1984; 150(7): 885–7.
   Google Scholar
• Lazarchick J, Stubbs T, Romein I, Van Dorsten JP, Loadholt CB. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986; 154: 1050–2.
   Google Scholar
• Ferri C, Bellini C, Desideri G, DiFrancesco L, Baldoncini R, Santucci A et al. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995; 44(4): 431–6.
   Google Scholar
• Taylor RN, Varma M, Teng NNH, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71: 1675–7.
   PubMed Web of Science ®Google Scholar
• Barden A, Beilin LJ, Burke V, Ritchie J, Michael CA, Walters BN. Relationships between plasma endothelin 1 and prostacyclin in normal and preeclampsic pregnancy. Hypertens Pregn 1996; 15: 25–38.
   Web of Science ®Google Scholar
• Mastrogiannis D, O’Brien WF, Krammer J, Benoit R. Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 1991; 165(6 pt 1): 1711–16.
   Google Scholar
• Ejim OS, Barradas MA, Mikhailidis DP, Poulter LW, Coumar A, Dandona P. A study of platelet fibronectin immunofluorescence in peripheral vascular disease and diabetes mellitus. Microcirc Endothelium Lymphatics 1989; 5(6): 373–90.
   Google Scholar
• Weiner CP. The mechanism of reduced antithrombin III activity in women with preeclampsia. Obstet Gynecol 1988; 72(6): 847–9.
   Google Scholar
• Lin KC, Chou TC, Yin CS, Ding YA. The role of aggregation of platelets in pregnancy-induced hypertension: a comprehensive and longitudinal study. Int J Cardiol 1991; 33(1): 125–31.
   Google Scholar
• Benedetto C, Massobrio M, Bertini E, Abbondanza M, Enriue N, Testa C. Reduced serum inhibition of plateletactivating factor activity in preeclampsia. Am J Obstet Gynecol 1989; 160(1): 100–4.
   Google Scholar
• Reinthaller A, Mursch-Edlmayr G, Tatra G. Thrombinantithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. Br J Obstet Gynaecol 1990; 97: 506–10.
   PubMedGoogle Scholar
• Deguchi A, Kawamura K, Wada H et al. [Plasma thrombomodulin levels in elderly subjects]. Nippon Ronen Igakkai Zasshi – Jpn J Geriatr 1991; 28(2): 205–9.
   Google Scholar
• Weiner CP, Brandt J. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia. Am J Obstet Gynecol 1982; 142: 275–81.
   PubMed Web of Science ®Google Scholar
• Chan P, Pan WH. Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients. Diabet Med 1995; 12(6): 504–7.
   Google Scholar
• Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G et al. Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380–5.
   PubMed Web of Science ®Google Scholar
• Agewall S, Wikstrand J, Suurkula M, Tengborn L, Fagerberg B. Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coagul Fibrinolysis 1994; 5(6): 895–904.
   Google Scholar
• Knobl P, Schernthaner G, Schnack C, Pietschmann P, Proidl S, Prager R et al. Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients [see comments]. Thromb Haemost 1994; 71(6): 692–7.
   Google Scholar
• Bruckert E, Carvalho de Sousa J, Giral P, Soria C, Chapman MJ, Caen J et al. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis 1989; 75(2–3): 129–34.
   Google Scholar
• Hirano T, Kashiwazaki K, Moritomo Y, Nagano S, Adachi M. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients. Diabetes Res Clin Pract 1997; 36(1): 11–18.
   Google Scholar
• Kovatz S, Arber I, Korzets Z, Rathaus M, Ben Aderet N, Bernheim J. Urinary kallikrein in normal pregnancy, pregnancy with hypertension, and toxemia. Nephron 1985; 40(1): 48–51.
   Google Scholar
• Millar J, Campbell S, Albano J, Higgins B, Clark A. Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample. Br J Obstet Gynaecol 1996; 103: 421–6.
   Google Scholar
• Elebute OA, Mills IH. Urinary kallikrein in normal and hypertensive pregnancies. Perspect Nephrol Hypertens 1976; 5: 329–38.
   Google Scholar
• He S, Bremme K, Blomback M. Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia. Blood Coagul Fibrinolysis 1995; 6(8): 703–8.
   Google Scholar
• Gao M, Nakabayashi M, Sakura M, Takeda Y. The imbalance of plasminogen activators and inhibitor in preeclampsia. J Obstet Gynaecol Res 1996; 22(1): 9–16.
   Google Scholar
• Easterling TR, Benedetti TJ. Preeclampsia: a hyperdynamic disease model. Am J Obstet Gynecol 1989; 160: 1447–53.
   PubMed Web of Science ®Google Scholar
• Zhang K, Wu Z, Ding M. The preliminary study of insulin resistance in pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih [Chinese J Obstet Gynecol] 1995; 30(8): 467–70.
   Google Scholar
• Cioffi F, Amorosa L, Vintileas A et al. Relationship of insulin resistance and hyperinsulinemia to blood pressure during pregnancy. J Maternal-Fetal Med 1997; 6: 174–9.
   Google Scholar